Usage of indocyanine green in urological robotic surgery

Czech version

Authors: Darina Pacigová ¹; Lukáš Gaduš ¹; Jiří Heráček ^1,2; Milan Čermák ¹; Jiří Kočárek ^1,2
Authors‘ workplace: Urologické oddělení, Ústřední vojenská nemocnice – Vojenská fakultní nemocnice, Praha ¹; Urologická klinika, 1. lékařská fakulta, Univerzita Karlova, Praha ²
Published in: Ces Urol 2018; 22(2): 99-105
Category: Review article

Overview

Indocyanine green (ICG) is a fluorescent dye with a wide spectrum of usage in minimally invasive urological surgery, where intravenous application of ICG can be used for identificaton of perfusion and tissue density. This review summarizes development, contemporary trends and also the future possibilities of ICG usage in robotic urology. During robotic kidney resection application of ICG is used for differentiation between tumorous tissue and healthy renal parenchyma. Administration of ICG during robotic radical prostatectomy can improve identification of the neurovascular bundle in nerve‑sparing procedures and detect the sentinel lymph node in pelvic lymph node dissection. The principle of ICG application can be used also in the effort to reduce post‑operative complications during robotic varicocelectomy. Future controlled trials are needed to evaluate if the use of ICG combined with the robotic surgical system will affect medical procedures and functional and oncological outcomes.

KEY WORDS

Indocyanine green, robotic surgical procedures, robotic kidney resection, robotic radical prostatectomy, robotic varicocelectomy.

Sources

1. Novara G, Ficarra V, Mocellin S, et al. Systematic review and meta‑analysis of studies reporting oncologic outcome after robot‑assisted radical prostatectomy. Eur Urol 2012; 62(3): 382–404.

2. Ficarra V, Novara G, Rosen RC, et al. Systematic review and meta‑analysis of studies reporting urinary continence recovery after robot‑assisted radical prostatectomy. Eur Urol 2012; 62(3): 405–417.

3. Landsman ML, Kwant G, Mook GA, Zijlstra WG. Lightabsorbing properties, stability, and spectral stabilization of indocyanine green. J Appl Physiol 1976; 40(4): 575–583.

4. Choi M, Choi K, Ryu SW, Lee J, Choi C. Dynamic fluorescence imaging for multiparametric measurement of tumor vasculature. J Biomed Opt 2011; 16(4): 046008.

5. Schaafsma BE, Mieog JD, Hutteman M, et al. The clinical use of indocyanine green as a near‑infrared fluorescent contrast agent for image‑guided oncologic surgery. J Surg Oncol 2011; 104(3): 323–332.

6. Brooker LGS, Heseltine DW, Inventors. Eastman Kodak Co, assignee. Tricarbocyanine infrared absorbing dyes. United States Patent 2895955 A; 1959.

7. Obana A, Miki T, Hayashi K, et al. Survey of complications of indocyanine green angiography in Japan. Am J Ophthalmol 1994; 118(6): 749–753.

8. Alander JT, Kaartinen I, Laakso A, et al. A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012; 2012: 940585.

9. Moore GE. Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 1947; 106(2745): 130–131.

10. Moore GE, Peyton WT, French LA, Walker WW. The clinical use of fluorescein in neurosurgery. J Neurosurg 1948; 5(4): 392–398.

11. KleinJan GH, van den Berg NS, Brouwer OR, et al. Optimisation of fluorescence guidance during robot‑assisted laparoscopic sentinel node biopsy for prostate cancer. Eur Urol 2014; 66(6): 991–998.

12. Tobis S, Knopf J, Silvers C, et al. Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for renal cortical tumors. J Urol 2011; 186(1): 47–52.

13. Bjurlin MA, Gan M, McClintock TR, et al. Near‑infrared fluorescence imaging: emerging applications in robotic upper urinary tract surgery. Eur Urol 2014; 65(4): 793–801.

14. Kumar A, Samavedi S, Bates A, et al. Use of intra‑operative indocyanine green and Firefly technology to visualize the „landmark artery“ for nerve sparing robot assisted radical prostatectomy. Eur Urol Suppl 2015; 2(14): eV36.

15. Golijanin DJ, Marshall J, Cardin A, et al. Bilitranslocase (BTL) is immunolocalised in proximal and distal renal tubules and absent in renal cortical tumors accurately corresponding to intraoperative near infrared fluorescence (NIRF) expression of renal cortical tumors using intravenous indocyanine green (ICG). J Urol 2008; 179(suppl): (abs. 386) 137.

16. Manny TB, Krane LS, Hemal AK. Indocyanine green cannot predict malignancy in partial nephrectomy: histopathologic correlation with fluorescence pattern in 100 patients. J Endourol 2013; 27(7): 918–921.

17. Borofsky MS, Gill IS, Hemal AK, et al. Near‑infrared fluorescence imaging to facilitate super‑selective arterial clamping during zero‑ischaemia robotic partial nephrectomy. BJU Int 2013; 111(4): 604–610.

18. Kočárek J, Chmelík F, Heráček J, Matějková M, Čermák M. Selektivní klamping při roboticky asistované resekci ledviny. Ces Urol 2016; 20(4): 257–258.

19. Manny TB, Patel M, Hemal AK. Fluorescence‑enhanced robotic radical prostatectomy using real‑time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol 2014; 65(6): 1162–1168.

20. Tomita K, Kageyama S, Hanada E, et al. Indocyanine green angiography‑assisted laparoendoscopic single‑site varicocelectomy. Urology 2017; 106: 221–225.

21. Ghosh A, Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 2004; 91(3): 528–539.

22. Nakajima T, Mitsunaga M, Bander NH, et al. Targeted, activatable, in vivo fluorescence imaging of prostate‑specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody– indocyanine green (ICG) conjugate. Bioconjug Chem 2011; 22(8): 1700–1705.

23. Krane LS, Hemal AK. Surgery: is indocyanine green dye useful in robotic surgery? Nat Rev Urol 2014; 11(1): 12–14.

24. Bates AS, Patel VR. Applications of indocyanine green in robotic urology. J Robot Surg 2016; 10: 357–359.